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RÉSUMÉ
La gestation chez le rat s’accompagne d’une diminution des effets des vasoconstricteurs,
laquelle est absente chez la rate avec prééclampsie expérimentale (PE), un désordre induit
durant la gestation et caractérisé par de l’hypertension et un état augmenté de
vasoconstriction. Ces manifestations sont considérées être associées aux changements de
l’activité de NaJK-ATPase (jompe à sodium) dans le muscle lisse vasculaire, qui contribue
elle à l’entretien d’un gradient électrochimique de Na et de K à travers la membrane
cellulaires. Cependant, elle joue un rôle important dans le reglage du tonnees vasculaire.
Les études précédentes ont prouvé que des ligands endogènes de la pompe à sodium sont
augmentés dans le plasma et utérine pendant la gestation et encore plus en PE. Dans ce
travail, nous proposons que l’activité et l’expression de la pompe à sodium sont modifiées
dans le muscle lisse vasculaire durant la gestation et à la PE. Nous avons mesuré les effets
inhibiteurs de la ouabaïne sur l’activité de la pompe et l’expression protéique de la sous
unité et de la NaJK-ATPase dans l’aorte de rate gestante avec ou sans PE. Pour développer
le modèle de preeclamptie expérimentale, nous soumettrons des rates gestantes à un
supplément sodique pour 7 jours (saline 0.9% , comme breuvage), correspondant à la
dernière des 3 semaines de gestation chez cette espèce. Des anneaux d’aorte des rates sont
suspendus dans des bains à organe et des réponses au KCI sont obtenues en l’absence ou en
présence de ouabaïne. L’activité de la NaIK-ATPase est mesurée indirectement par la
relaxation au KC1 dans une solution physiologique sans K. L’expression de la sous-unité
et 1 est mesurée par buvardage Western. La ouabaïne produit des contractions sur les
anneaux d’aorte, cette réponse est augmentée dans une solution faible en K, de même que
chez la non-gestante sous diète forte en sel. Le groupe gestant s’est montré résistant aux
effets vasoconstricteurs du KC1, mais pas les rates avec prééclamptie expérimentale. La
relaxation au KC1 est réduite dans l’aorte de rate gestante comparaterement à la non
gestante. La ouabaïne inhibe cette relaxation, avec de façon plus importante durant la
gestation. L’expression de la sous-unité cd de la Na!K-ATPase est réduite dans les aortes
de rate gestante et augmentée dans la prééclampsie. L’ensemble de nos résultats suggèrent
que l’activité de la NaJK-ATPase est augmentée dans les muscles lisses vasculaires durant
la gestation pour favoriser les l’hyperpolarisation des cellules musculaires lisses et
Vdiminuant ainsi leurs réponses aux vasoconstricteurs. Le PE diminue l’effet inhibiteur de
l’ouabaïne, ce qui suggère que l’activité de pompe à sodium serait réduite dans cette
condition. L’expression augmentée de la protéine de la sous-unité al bourrait être un effet
compensatoire à cette réduction d’activité.
Mots Clés 2 Prééclampsie, NaJK-ATPase, supplément sodique, ouabaïne, aorte, muscles
lisses vasculaires, vasoconstriction
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ABSTRACT
During late gestation in rats, resistance to vascular responses to vasopressor agents is
observed, but absent in rats with experimental preeclampsia (PE), a pregnancy-induced
disorder characterized by high blood pressure and increased vasoconstriction. These
manifestations are believed to be associated with changes in the activity of Na!K-ATPase
(sodium purnp) in vascular smooth muscle, since it contributes to the maintenance of an
electrochemical gradient of Na and K across ceil membrane and plays a major role in
vascular tone regulation. Previous studies showed that endogenous sodium pumps ligands
are increased during pregnancy and even more in PE. In the present work, we hypothesize
that sodium pump activity and expression in vascular smooth muscle would change in
response to pregnancy and PE. Thoracic aortas of normal pregnant and of experimental
preeclamptic rats were assayed for inhibitory effects of ligands of the sodium pump, as well
as for protein expression of Œ-isoform of NaJK-ATPase. Non-pregnant and pregnant rats
were used; experimental preeclamptic model was developed by giving pregnant rats 0.9%
NaC1 supplement to drink for the last 7 days of gestation. Responses of aortic rings to KC1
were obtained in the presence of ouabain, and inhibitor of sodium pump, in normal (5.8
mM) or low (2.0 mM) potassium medium. Relaxations to KC1 were obtained by incubating
aortic rings in K-free solution and precontracting with phenylephrine (PhE) in the
presence of inhibitors of the sodium pump. KC1 was gradually re-added into the bath to
induce relaxation. Protein expressions of cd and ct3 isoforms of sodium pump were
measured by Western blot. It was found that Ouabain produced contractions on isolated
aortic rings, which was increased in low K solution, as well as in non-pregnant rats with
high salt diet. Pregnant group showed refractoriness to vasoconstrictor effects of KCY, but
experimental preeclamptic rats not. Relaxation to KC1 was significantly reduced in aorta
from pregnant compared to non-pregnant rats. Ouabain produced concentration-dependent
inhibition in this relaxation, that was significantly larger in aorta of normal pregnant than in
non-pregnant rats. Expression of al subunit of sodium pump did flot change in aortas of
pregnant rats, but was significantly increased in aorta of preeclamptic rats. Based on the
above observations and experimental results, we concÏude that sodium pump in vascular
smooth muscle is increased during pregnancy to favor vascular smooth muscle
vii
hyperporization and thus reduce vasoconstriction. Experimental PE decreased the
inhibitory effect of ouabain. which suggests sodium pump activity is decreased in
pathological state of PE. Increased protein expression of al isoform may be a biological
compensational effect.
Key words: Preeclampsia, Na/K-ATPase, sodium supplement, ouabain, aorta, vascuar
smooth muscle, vasoconstriction
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1. INTRODUCTION
1.1 Pregnancy
In human being, normal pregnancy causes profound physiologic changes in severai
systems to adapt to a new situation with different challenges and pregnancy needs. These
maternai changes concem cardiovascular, hematological, pulmonary, urinary and
endocrine systems, etc. for exampie. there is a large expansion of plasma volume, an
increase in heart rate, cardiac output, ail components of renin-angiotensin-aidosterone
(RAAS) system, and elevated sait retention. Ail these body changes are made to
accommodate the demands of gestation.
1.1.1 Vascular Functions in Pregnancy
During normal pregnancy, dramatic changes take place in cardiovascular system, such as:
increased heart size (by about 12%), increased cardiac output by (30-40%), increase heart
rate by about 15% beats/ mm, increase renal blood flow (by about 70%) and increase
blood volume (by 50%), decrease peripheral vascular resistance and blood pressure [123].
Despite the large increases in blood volume and cardiac output (Fig.1) [37], arterial biood
pressure does not rise during normal pregnancy. In contrast, the diastolic blood pressure
decreases in mid-pregnancy and then graduaily increases after 26 to 2$ weeks to pre
pregnancy values at term (Fig.2) [38]. The decreased blood pressure resuits from
decreased systemic vascular resistance (SVR). The SVR decreases to a minimum at
midpregnancy foliowed by a graduai rise until tenu [1].
Moreover, plasma renin activity, plasma angiotensin II (ANG II) and aldosterone level
increase 5 to 10 times during this period. However, the normal pregnant women also have
some refractoriness to the pressor effects of exogenously given ANGII. It lias been shown
2that nulliparous women who later become preeclarnptic lose this refractoriness prior to
developing clinical signs ofPE [2].
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Figure 1. Changes in cardiac output (upper panel), stroke volume (middle panel), and
heart rate (Iower panel) throughout pregnancy in human. P-P, pre-pregnancy values; PN,
values afler parturition. (From [37] Hunter S, Robson S: Br Heart J 6$: 540, 1992)
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figure 2. Blood pressure profiles (sitting and lying) during pregnancy. (From [38]
MacGiHivray I, Rose G, Rose B: Clin Sci 37: 395, 1969)
41.1.2 Mechanisms for Pregnancy-Induced Decrease in Blood Pressure
As mentioned, the decrease in bÏood pressure is attributable to the fali in decreased SVR,
which is believed to link to diminished constriction of blood vessels [79]. The exact
mechanisms for the fail in SVR during pregnancy are poorly understood. Several theories
have been proposed for this hemodynamic adaptation, such as down-regulation of
membrane receptors for vasopressor ligands (vasopressin, norepinephrine, etc.) in
vascular tissues, increased liberation of an endogenous vasodilator (prostacyclin, nitric
oxide, etc.) acting as physiological antagonist to vasopressor [66]. However, pregnancy
associated blunted responses to vasoconstrictors has been observed in isolated blood
vessels of pregnant rats in the presence and absence of endothelium, indicating that the
phenomenon is not consequent to autonomous reflex or to some endothelial dysfunction
[65, 76-79]. More recent hypothesis proposes smooth muscle-relaxing effects of the
elevated progesterone level, the presence of the one or more circulating substances
exerting a vasodilatory effect on the arterial and venous vasculature. This may involve
nitric oxide (NO), prostaglandins or atrial natriuretic peptide (ANP) [1]. Attention lias
focused on the production of NO in pregnancy, since it plays a role in the control of
vascular resistance in human [76]. However. no single mechanism emerges as the only
and major one.
1.2 Pharmaco-mechanical Coupling, the NaIK-ATPase
1.2.1 Membrane Hyperpolarization in Pregnancy
A promising explanatïon for the decreased vascular resistance is membrane
hyperpolarization in vascular smooth muscle celis. Electrophysiological data have shown
that resting membrane potential is more negative in vascular smooth muscle celi
membrane of vasculature during pregnancy in rat [80]. This pregnancy-induced
hyperpolarization is believed to relate to alteration in cellular active transport system
across the plasma membrane, change in activity of NaIK-ATPase (also known as the
5sodium pump). This transport system is believed to play an important role in maintaining
membrane potential. Increased sodium pump activity may promote hyperpolarization in
plasma membrane, and reductions of its activity can result in increase muscle contraction
[67]. Studies of blood ceif s from patients with essential hypertension have generally
demonstrated reductions in NaJK-ATPase activity [6$]. In the present study, we
investigate the activity and protein expression of the Na/K-ATPase in aortic rings of rats
to attempt to determine its contribution to pregnancy-induced decrease in blood pressure.
1.2.2 Biological Functions ofNa/K-ATPase
The sodium pump is responsible for establishing and maintaining the electrochemical
gradient in animal celis. for every molecule of ATP hydrolyzed. three Na ions from the
intracellular space are extruded and two K ions from the external medium are uptaken
(Fig.3). Thus, the sodium pump contributes substantially to the maintenance of cellular
ionic homeostasis. The electrochemical gradients are then hamessed by other membrane
proteins for a variety of essential cellular functions, including electrical membrane
potential changes mediated by ion channels, osmotic balance of the cdl, active uptake of
molecules, like neurotransmitters, amino acids, sugars, nucleosides, and extrusion of Ca2.
It is also thought to be critically involved in functions such as cellular growth and
differentiation, as well as contraction ofvascular smooth muscle. Therefore the inhibition
of the Na pump produces an ionic redistribution that may promote the increase in
vascular tone [3].
1.2.3 Subunit Compositions of Na/K-ATPase
The NaIK-ATPase is a member of a large family of P-type ATPase, which hamess the
energy derived from the hydrolysis of the terminal pyrophosphate bond of ATP to drive
the transport of cations such as Na, K, H, Ca2. It is composed of 3 protein subunits (Œ,
f3,y).
6+ +.Figure i. The sodium pump. This camer protem actively pumps Na out and K into a
ceil against their electrochemical gradients. For every molecule of ATP hydrolyzed, three
Na are pumped out and two K are pumped in. The specific inhibitor ouabain and K
compete for the sarne site on the extracellular side of the pump. (From [119) Bruce
Alberts et ai: Molecular Biology ofThe Ceil, Fourth Edition, Chapter 11.)
The ci subunit, which is referred to as the catalytic subunit. is responsible for most ofthe
activities. It contains also intracellular ATP hydrolytic site and the extracellular digitalis
glycoside-binding site. It has a relative mass of 100-113 KDa, depending on the isoforms
cri to cr4. ci subunit crosses the membrane 10 times, forming trans-membrane domains
Ml to M10; both N- and C- termini are localized on the cytosolic side (Fig.4).
3g
Kand ouabain
binding site
sodium
&ectrochemical
gradient
I
o
potassium
eIectrochemica
gradient
L
Na-binding
site
CYTOSOL
fAD] + P1
2)
7The f3 subunit is highly glycosyiated and has a relative molecular mass of about 60 KDa.
The mass ofthe protein moiety of this unit is 36-3 8 KDa, depending on the isofors f31- f33.
The f3 subunit crosses the membrane only once, and the N-terminus is localized on the
intracellular side of trans-membrane (fig.4). The proper roles of these proteins are sf11
not entirely clear. More recent resuits have shown that the f3 subunit makes direct contact
with the a subunit [4], thereby stabilizing the a subunit and assisting in its transport from
the endoplasmic reticulum to the plasma membrane [5].
The third subunit of NaIK-ATPase, the ‘y subunit of 7-11 KDa, was first identffied as a
component invo Ives in the binding of t3Hl ouabain, but ‘y subunit expression is not seen
in ail tissues where a, f3 expression is otherwise easily identified. Like the f3 subunit, the y
subunit spans the plasma membrane once but unlike the f3 subunit, its amino terminus is
extracellular. A putative 3-dimensional model of the u., f3 and y subunits of the NaJK
ATPase is shown in figure 4 [39].
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Figure 4. Putative three-dimensionaÏ model of the topological structure of the NaIK
ATPase (From [120] Mobasheri A et ai: Bioscience Reports. Vol. 20, N0.2: 55, 2000)
81.2.4 Distribution and Physiological Function ofNa/K- ATPase
Thus far 4Œ, 3j3 and ly isoform subunit have been identified in mammals [6, 9]. Each
isoform has a unique tissue distribution and is encoded by a separate gene, and may be
altered in pregnancy or pathologic processes, such as hypertension [6]. The al
polypeptides are ubiquitously distributed in animal ceils whereas the remaining a
isoforms exhibit a more restricted tissue specific and developmental pattern of expression.
The a2 isoform is expressed most abundantly in cardiac muscle, skeletal muscle, adipose
tissue and guai ceÏls in the brain [10, 11], while the a3 isoform is found in higli
concentrations in neurons [10, 11] and cardiac muscle [12, 10]. The a4 isoform appears
to be specific to the testis [7].
Expression of f31 subunit polypeptides has been detected in many tissues from which
NaJK-ATPaes has been isolated, such as brain, heart and kidney [24]. In contrast, the f32
isoform is more tissue-specffic. It appears to function as an adhesion moiecule on guai
ceils specifically invoived in mediating interactions between neurons and glia [13]. The
f33 isoform is the most recently described member of the f3 isoform gene family and is
expressed predominantiy in the testis but also in the brain, kidney. lung, liver, etc. [10,
12]. The function of the f3 subunit has yet to be elucidated.
Aithougli the enzyme is a hetero-dimer consisting of at least one a and f3 subunit, studies
suggested that the kinetic properties are largeiy dictated by the catalytic a isoform. The
diversity of NaIK-ATPase subunit isoforms and their complex spatial and temporal
patterns of cellular expression suggest that NaIK-ATPase isozymes perform speciaiized
physiological function. It is expected that their expression and!or function are altered in
pathogenic states or conversely that alterations in their expression and/or function
contribute to the disease.
91.2.5 Function of Na/K-ATPase in Vascular Tissues
The vascular sodium pump structure is similar to that found in other tissues, but with
some particularities. The presence of these small structural differences in the ATPase
may permit variations in the responses and regulation of sodium pump function between
vascular smooth muscle and other tissues [17]. The enzyme of vascular tissue has been
difficult to isolate and purify using conventional protein purification techniques, due to
low number of copies of the pump in these cells [14]. Nevertheless, the importance of
the Na gradient in blood pressure regulation has long been recognized, and many studies
have been carried out to characterize the enzyme and its role in modulating vascular
contraction [14-16]. Studies on the regulation of its activity have shown that the vascular
enzyme can be stimulated by treatments that increase intracellular Na concentration
and/or decrease intracellular K concentration [1$]. In the present study, low K solution
was applied to increase the activity of the sodium purnp and thus the inhibitory effect of
ouabain, a potent blocker of sodium pump. More recent studies have shown that the
increase in intracellular Na by mechanical strain [19, 20] or chronic treatment with
ouabain [19], up-regulate ai- and a2- isoforms expression ofthe sodium pump in aortic
smooth muscle ceils.
NaIK-ATPase plays an essential role in the control ofvascular smooth muscle tone. Thus,
the inhibition of this enzyme by cardiac glycosides or K-free solution produces an
increase in vascular tension in several vessels [21, 22]. The accepted cellular mechanism
involved in the contraction afier the Na pump blockade is that an increase in intracellular
Na concentration causes an increasing Ca2 entry into celis through the inversion of
NaJCa exchange [23, 25]. The Na/Ca exchanger is a transporter present in the plasma
membrane catalyzing the counter-transport of three Na for one Ca2 and helps to
maintain steady Ca2 balance. It is prirnarily a Ca2 extrusion rnechanism, under normal
physiological conditions. When the sodium pump is inhibited, internai Na rises,
prornoting reverse exchange (Na goes out and Ca2 cornes into the celi), leading to an
elevated internai Ca2, and thus the contraction.
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1.2.6 Specific Inhibitors ofNaIK-ATPase
The NaIK-ATPase is specifically inhibited by a series of naturally occurring steroids,
termed cardiac glycosides, such as ouabain and digitalis (Fig.5). Cardiac steroids compete
with K and bind reversibly to an extracellular side of the NaIK-ATPase (Fig.3) and
inhibit ATP hydrolysis and thus ion transport. K lowers the affinity of the enzyme for
cardiac steroids at their high affinity extracellular binging site. Cardiac steroids,
especiaÏly water-soluble ouabain, have ofien been used to identify Na/K-ATPase and to
study ion transport mechanisms involved in this system. Inhibition of the sodium pump
by cardiac steroids has some clinical use. Application of these substances, especially of
digitalis and its congeners, helps to increase muscular contractility of the failing heart,
possibly by indirectly inducing an elevation in the Ca2 concentration in the myocardium.
As described above, the Œ-subunit is the specific receptor site for digitalis glycoside-like
inhibitors and is represented by three well defined fi.rnctional isoforms (cd, Œ2 and a3).
They are distributed in a tissue-specffic fashion; exhibit differential sensitivity to the
inhibitory ligands [70]. For example, ouabain displays high affinity to a3 isoform
(predominant in nerve endings) while al isoform (predominant in vascular smooth
muscle) is more sensitive to inhibition by marinobufagenin (MBG) [70]. Besides, studies
in the rat showed a consecutive inhibition of the a2 and al isoforms by MBG with high
and low affinity, respectively [71].
1.2.7 Endogenous Digitalis-Like Factors
Since cardiac glycosides were suggested as endogenous physiological regulations ofheart
muscle contraction [61], there lias been a long search for natural endogenous ligands of
the sodium pump and many studies have then looked at involvement in maintenance of
high blood pressure in hypertension. Mammalian plasma was found contain several
substances that inhibit the sodium pump and interact with digitalis antibodies [28, 32].
Ouabain-like factor (OLF) was the first mammalian endogenous digitalis-like factor
(EDLF) to be purified [31]. Figure 6 shows the structure of ouabain and its analogs [99].
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Figure 5. Structure ofthree cardiac glycosides
But recent evidence suggests that at least one of the mammalian EDLFs has a
bufodienolide structure [33-35]. Bufodienolides are cardioactive steroids that were
initially described in amphibian, and differ from cardenolides in having a doubly
unsaturated six-membered lactone ring at the Cl 7 position of the steroid nucleus. It lias
been shown that human plasma and urine contain material that cross-reacts with
antibodies against one of the toad-derived bufodienolides, marinobufagenin [33] (see
Fig.5).
c
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ouabain marinobufagenin
12
Figure 6. Structure ofthe ouabain analogs (from [99] Manunta P, Hamilton BP, Hamlyn
JM: Hypertension 37 (part 2): 472, 2001.)
Eievated amount of EDLFs has been found in hypertensive animais and humans [26, 27].
They are thought to contribute to the pathogenesis of hypertension [3, 29]. Expansion of
plasma volume is known to stimulate endogenous cardiac glycosides, e.g. EDLFs [30]. It
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lias been hypothesized that in volume-expanded hypertension, cardiac glycosides are
stimulated to promote natriuresis via inhibition of the sodium pump in renal tubules [3].
However, excessive production of EDLFs may also inhibit the sodium pump in vascular
smooth muscle and resuit in vasoconstriction. Therefore, sodium pump inhibition would
induce increased natriuresis and would protect blood volume at the expense of an
elevated blood pressure [3, 72].
Late pregnancy is indicated to be associated with plasma volume expansion involving
renal sodium and fluid retention [113]. It lias been demonstrated increased level of
cardiac glycosides in pregnancy and hypothesized that they are involved in pathogenesis
of pregnancy-induced hypertension [114, 115]. Subsequent studies demonstrated
increased level of EDLF s in normotensive pregnancy [116-11$] and in PE [69, 115, 117,
118]. Table 1 shows the EDLF values in plasma from control women vs women with
normal pregnancy and in PE [69].
Evidences that an elevated plasma cardiac steroids may raise the blood pressure is that
increased plasma cardiac steroid levels were correlated with tlie height of blood pressure
in volume-expanded hypertension [122], including pregnancy-induced hypertension
[114], the administration of affinity-purified ovine digoxin antibody fAB fragments
lowers the blood pressure in PE [121], and that antibody to MBG lowers blood pressure
in pregnant rats on a higli NaCI intake [133]. However, putative role of EDLFs in
pregnancy and PE is stiil controversial and there is little information regarding the change
in sodium pump activity accompanying volume-expansion caused by elevated amount of
endogenous sodium pump ligands during end gestation and in PE. Recently publislied
data by fedorova et al is the first report that administration of an anti-MBG antibody to
NaCl-loaded pregnant rats reduces blood pressure and increases vascular smootli muscle
sodium pump activity [133].
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Table 1. Plasma levels of marinobufagenine (MBG) and ouabain-like
compound (OLC) in non-pregnant control individuals, the third
trimester of normal pregnant women and patients with PE. (From [69J
Lopatin DA et ai: Journal of Hypertension 17: 1179-1187, 1999)
MBG (nM) OLC (nM)
Non-pregnant control 0.19 ± 0.04 (11) 0.297 ± 0.037 (11)
Normal pregnancy 0.625 ± 0.067 (6) 0.32 + 0.07 (6)
Preeclampsia 2.63 ± 0.10 (15) 0.697 + 0.16 (15)
1.3 Preeclampsia
1.3.1 Definition ofPreeclampsia
Preeclampsia is a complex pregnancy disorder characterized by hypertension and
proteinuria, developing afier 20 weeks gestationai age. Hypertension refers to blood
pressure of 160 mm Hg or greater systolic or 110 mm Hg or greater diastolic, recorded on
at least two occasions at least 6 hours apart with patient at bed rest. Proteinuria is defined
as the urinary excretion of 0.5 g protein or more in a 24-hour specimen. High blood
pressure in PE is mainly due to a reversai of the vasodilation characteristic of normal
pregnancy, replaced by marked increases in peripheral resistance [92].
PE is associated with substantial risks. For the fetus, these include intrauterine growth
restriction, death, and prematurity with inherent morbidity, whereas the mother is at risk
for eclampsia, renal failure, pulmonary edema, stroke, and death. PE is unique to human
pregnancy, and there are stili no clinically useful screening tests to identify women in
whom it will develop. Antihypertensive therapy lowers maternai biood pressure but does
not improve fetal outcomes; the only “cure” is the delivery ofthe infant.
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Compared to normal pregnancy, PE is associated with maternai hypertension, decreased
circuiatory volume, and reduced activation of RAAS [36]. It has been observed that the
vascular reactivity to vasopressor ANGII is greatly enhanced in PE compared with that of
normal pregnancy [2]. Other manifestations such as an increase in maternai vascular tone,
enhanced piatelet aggregation, and reduced uteropiacental blood flow are observed [75];
Understanding the mechanisms producing these changes in hemodynamics and
vasculature in PE wili give strong dues to the overali pathogenesis ofthis disorder.
1.3.2 Causes ofPreeclampsia
Preeclampsia remains a leading cause of maternai and fetai morbidity and mortality
worldwide. Despite extensive research, the mechanisms that cause PE are stiil debated.
At present, 4 hypotheses are intensiveiy investigated: inadequate piacental implantation,
the existence of a factor X reieased from the placenta into the maternai biood causing
endothelial celi damage [73], immune maladaptation, and genetic predisposition.
The placenta is considered the pathogenic focus for ail manifestations of PE, because
delivery is the only definitive cure for this disease. Defective placentation and placental
vascular insufficiency are the starting point of PE. Early in normal gestation, trophoblast
celis invade placentai bed, leading to remodeiing of the spiral arteries into maximaily
dilated low resistance vascular channels, unable to constrict to vasoactive stimuli [93, 94],
thereby guaranteeing a higli flow volume to the uteroplacental bed (see Fig.?) [73]. In
women who eventualiy develop PE, the invasion of the uterine spiral arteries is
incomplete, with the vessels remaining thick-walled and muscular [95], and with failure
of endothelium-dependent relaxation [96]. The cytotrophoblasts in preeclamptic women
seem to fail to express vascular-type adhesion molecules, which impair their ability to
form sufficient connections with the uterine vessels [94. 97, 9$].
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Figure 7. Trophobalst invasion into the spiral arteries in the placental bed in normal
pregnancy and in preeclarnpsia. (from [73] VanWijk MJ et ai: Cardiovascular Research
47: 39, 2000.)
The endothelium, a monolayer of epithelial ceils, is in direct contact with the biood and
constitutes a physical and metabolic barrier. According to the wide range of functions
displayed by endothelial celis, it is an attractive hypothesis that endothelial celi
dysfunction plays an important role in the pathophysioiogy of PE. To link the placentai
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abnormalities to the generalized endothelial dysfunction seen in PE, the existence of a
factor X, reieased from the placenta into the maternai circulation, was proposed [73]. The
disturbed placentation supposedly leads to hypoperfusion of the placenta and ischemia,
resulting in the release of one or more unidentified factors from the placenta. factor X
then causes the late vascular dysfunction of PE, consisting mainly of generalized
endothelial dysfunction, resulting in vasoconstriction, activation of the coagulation
system and redistribution of fluids, the symptoms of PE, and often in fetal growth
restriction [73].
Another hypothesis about the etiology of PE postulates that abnormal placentation, with
failure of the trophoblast to induce physiological dilation and remodeling of spiral
arteries, is caused by a maternai immunological response to foreign paternal antigens of
the fetoplacental unit [100]. This theory is supported by the greater incidence of PE
among multiparous wornen becoming pregnant with a new partner. Lymphocytes of
preeclamptic subjects do not show the cellular hyporesponsiveness to fetal celis that is
typical of normal pregnancy [101], the activity of circulating natural killer ceils,
neutrophils and cytokines, such as TNF-ct, IL-6, IL-2 and IL-12 is increased [100, 102].
Besides, in PE HLA-G, a surrogate auto-antigen known to prevent recognition by natural
killer celis is not expressed as general in the placenta as in normal pregnancy [103]. The
resulting activation of leukocytes in the deciduas, can cause release of cytokines, elastase
and oxygen free radicals, ail ofwhich cal interact with endothelial function.
A familial factor in the pathogenesis of PE bas been recognized for many years, but the
exact mode of inheritance and the interaction between maternai and fetai genotypes are
stili under discussion. Several studies have shown an increased frequency of PE in the
sisters, daughters and granddaughters, but not the daughters-in-low, of women who have
had the disease [104-106]. These data have been interpreted to mean that the putative
susceptibility genes act through the mother. More recently it was suggested that PE is a
polygenic trait [107]. Implicated in this process are the angiotensin gene, the endotheliai
nitric oxide synthase gene, and genes involved in TNF-u-production, thrombophilic
disorder, hypertension and obesity [10$-112]. Thus far most studies investigating the role
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of genetics in PE have been small scale and a large database of genotypes, present n
women with PE and their chiidren, is needed to elucidate to which extent genetics are
involved in PE.
1.4 Experimental Model ofPreeclampsia
PE bas been a recurrent research area for many years. The multitude of systems invoived
in the physiopathology of PE and their complex interactions provide an intriguing
challenge. A major probiem in PE research is the lack of a valid animal model that can
enable a more thorough investigation of physiopathology this disease. Over the past
decade, various mammalian moUds have been proposed to study the pathogenesis
implicated in PE, including:
1. Inhibition ofnitric oxide (NO) synthesis [40]
2. Reduced ofthe uterine perfusion [41]
3. Transfecting animais with genes ofhuman renin-angiotensin system [46]
4. Stimulating the sympathetic nerve [47]
5. Administration of endotheÏin-l during late pregnancy [4$]
6. Administration of low doses ofendotoxin [49]
Although providing valuable information on relevant mechanisms, these models are
not specific to the pregnant condition and occasionally are associated with fetal
mortality [42]. Thus, since PE is a pregnancy-specific disease, none of these
approaches would represent an adequate animal model.
An ideal animai modei ofPE should fulfiui some criteria:
• It shouÏd exhibit increase in arteriai pressure similar to that occurring in PE.
• It should occur oniy in pregnant animal.
• It should manifest many ofthe physiologicai characters ofPE.
• The PE-condition induced should be relieved by delivery ofpups.
• It should be feasibie in smaii animals, ideally.
• It should be simple to perform and reproducibie.
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1.4.1 High Sodium Intake Model
Sodium supplementation during gestation can provide an excellent animal model to
study the mechanisrns impiicated in PE. It’s been demonstrated that high sodium intake
(0.9% NaCI) to the rats at the end of gestation, the last 7 days ofthe 22-days pregnancy
in this species, prevented the decrease of blood pressure and reversed the diminish of
vascular reactivity normally observed in this period [42,74] (fig.8). In women, blood
pressure already decreased by the end of the first trimester and retumed to pre
gestational values approaching term [43]. In pregnant rats, blood pressure does flot
change until the seventeenth and eighteenth days and then gradualiy decreases until
term (23rd days) [44]. Thus, the cardiovascular changes observed in the last week of
pregnancy in rats correspond to the ones occurring during the second trimester in
pregnant women [42, 74]. Women who subsequently develop PE at the end of gestation
commonly do flot show the characteristic decrease in blood pressure at the second
trimester.
As shown in Figure 8, before sodium supplementation (day 12 to dayl4), systolic blood
pressure was similar in both groups of pregnant rats. Sodium supplement 0.9% did flot
affect systolic blood pressure in non-pregnant rats. However, pregnant rats receiving
0.9% NaCI supplement did not show the expected decrease of blood pressure observed
in control pregnant rats [42]. It was aiso observed that sodium suppiement of 0.9%
NaCI decreased the activity of renin-angiotensin-aldosterone system (RAAS) in non
pregnant and pregnant rats. However, the decreased RAAS induced by high sait intake
was flot associated with any change in systolic blood pressure in non-pregnant rats [45],
but with suppression of the decrease in blood pressure in pregnancy. This resuit
suggests that the mechanisms controliing blood pressure are easily perturbed by high
sodium intake during pregnancy [42].
20
Non Pregnant
12 13 14 15 16 17 18 19 20 21 22
Figure 8. Arterial pressure of the rats in normai diet or in diet with sodium
supplement (Adapted from 1421 Beausejour et ai: A.J.P. 285: 11375, 2003)
In a parallel study, contractile response to vasoconstrictors (phenylephrine, KC1,
arginine vasopressin) in the aortic rings of normal pregnant and pregnant rats on high
sodium intake have also been measured, and increased responses to these
vasoconstrictors in aortic rings of pregnant rats on 0.9% sodium supplement compared
with pregnant rats on normal water was observed [74]. This demonstrated that
augmented sodium intake during gestation in the rat is linked with the reversal of
gestational-associated resistance to vasopressors and indicates that this is an
experimental model showing some features ofgestational hypertension [74].
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1.4.2 Stress in Pregnancy Model
Stress in pregnancy rats was here proposed as animal model for human PE [51]. This
model is based on epiderniological data on human populations, showing that stress has
unfavorable effects on pregnancy and resuits in a greater incidence of PE and
intrauterine growth retardation [52. 53]. In establishing this experimental model, the
rats were exposed to some sound stimulus associated with overpopulation in cages
between days 7 and 14 over 22 ofpregnancy. Pregnant female Wister rats experienced
more manifestations from intense stress than did the non-pregnant animais, such as high
arterial blood pressure, increased proteinuria, higher adrenal weight, iower
endothelium-derived relaxing factor activity, decreased weight gain, lower fetal weight
and greater number of fetuses. The alterations found in the rats were similar to those
occurring in human PE [51].
As we know, PE occurs spontaneously only in the human species. Humans are the most
intellectually endowed living beings and lead a complicated life in society in which
behaviorai rules control most primitive emotional reactions. Thus, in some individuais,
many aspects of daily routine may lead to intense chronic stress. Given these
considerations, Nitol et ai believe that intense stress during pregnancy may provoke or
favor PE [51].
1.4.3 Other Model: Adaptive Transfer ofActivated Thi Celis
Experimentally induced PE on the basis of immunological imbalances associated with
endothelial ceIl dysfunction has also been reported. This immunologicai approach
proposed that the immune system is important in the course of pregnancy and that it
possibly participates in the etiology of PE [50]. This animal model was developed by
transferring activated BALB/c Thi-like splenocytes into allogeneically pregnant BALB/c
female mice during late gestation (on days 10 and 12 of pregnancy). The authors
hypothesized that activated Thi ceils will negatively affect late allogeneic and induce PE
like symptoms [50]. The model mimicked the symptoms of PE, i.e. incrcased blood
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pressure and glomerulonephritis accompanied by proteinuria, which were flot detectable
in non-pregnant recipients of activated Thi -like celis. Adoptive celi transfer adversely
affected the outcome of pregnancy by increasing fetal rejection, with uterine immune
ceils showing an inflammatory profile. This excessive maternai inflammatory response
leads to generalized endothelial ceil dysfunction [50].
The study resuits showed that adoptive transfer of Th 1 -like celis induces an increased
cytokine production (TNF- Œ and IL-12) and Thi marker (CCR5) in uterine lymphocytes.
Thi cytokines can direcfly damage organs and destroy vessels [57], which is believed to
be induced by direct interaction of immune ceils (secreting Thi cytokines) with the
vessels [50]. Before this, it’s also been reported that Thi celis play a detrimental role
during mammalian pregnancy [54], [55]. And there is a close relationship between
activated Thi immune ceils and PE in hurnans [56].
How the transfer of activated Thi-like ceiis provokes these physiological abnormalities
exciusively in pregnant animais? It is believed that since the transferred celis produced
predominantly Thi-type cytokines, they expand and stimulate host celis primed to
paternal antigens toward the secretion of inflammatory cytokines [58]. Increased
secretion of Thi cytokines by activated host celis or, in other words, an inflammatory
host response, was in fact proposed to be the main cause leading to PE in humans [59],
[60].
In summary, both of the latter two animai models, to some degree, may present some
features and physiologicai changes that resemble those obseiwed in PE. But since PE is
mainiy characterized by maternai hypertension, which is resulted from enhanced vesse!
constriction, and is associated with enhanced vascular reactivity [38] and reduced activity
of RAAS [36], only the first mode! — 0.9% NaC1 supplementation, can represent these
aitered hernodynamic parameters sirnilar to those occurring in PE, and thus make a
valuable tooi to study the mechanism implicated in PE [74].
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2. Research Objectives
The evidence that endogenous sodium pump ligands (SPL)/endogenous digitalis-like
factors are increased during pregnancy and even more in PE [69,133] suggests that
alteration in activity and expression of vascular sodium pump may contribute to these
special physiological or pathological states. The purpose of this work is to investigate the
inhibitory effects of ligands of the sodium pump and protein expression of Œ subunit of
the NaIK-ATPase in isolated aorta of rats. The objectives are approached by the
following ways:
1. Evaluate the contractile effect of the inhibition on the NaJK-ATPase with
ouabain in thoracic aorta of normal pregnant and experimental preeclamptic
rats in normal physiological solution or in reduced potassium medium. We
investigated the inhibitory effect of ouabain as the ftrst research object
because it is a well-known compound and the first discovered cardiac steroid
that selectively and potently blocks the plasmalemmal sodium pump in a
variety of ceil types. Ouabain like compound was the first mammalian
endogenous digitals-like factor to be purified [31]. The rat vascular sodium
pump is very resistant to inhibition by cardiac glycosides ouabain, therefore
high concentrations of this compound (0.1-f mM) were needed to observe a
clear response [124-126].
2. Measure the inhibitory activity on KC1-induced relaxation by three sodium
pump ligands (ouabain, MBG and digoxin) in a K-free solution. The
concentrations used of MBG (0.01-0.1tM) were based on the physiological
concentration. Digoxin worked as a reference and similar concentrations (0.1 -
1.0 iM) were applied.
3. Measure the protein expression of a-subunit of NaK-ATPase in the aorta of
normal pregnant and experimental preeclamptic rats.
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3. Materials and Methods
3.1 Animal
Female Sprague-Dawley rats (Charles River Canada. St-Constant, PQ, Canada) aged 10-
11 weeks were mated with age-rnatched males. The morning on which vaginal smears
were found to contain spermatozoa was labeled Dayl of pregnancy. The pregnant
females were then placed in individuai caged until used on the 22d day of gestation.
Virgin rats of the saine age served as controis. Ail the animais were fed a normai diet
containing 0.23% NaC1. Control animais (pregnant and non-pregnant) had tap water
during ail the treatment period. The experimental group received 0.9% NaC1 solution as a
beverage for 7 days, starting on day 15 of experimentation, corresponding to the last
week of gestation, these are called experirnental preeclamptic rats. At the end of
treatment (day 22 of gestation), the animais were decapitated, and thoracic aorta were
coliected rapidly and placed in coid krebs bicarbonate solution (KBS) or stored at -80°C
for western blot analysis.
3.2 Materials
Chemicals were purchased from Fisher Scientific (Montreal, PQ, Canada). Ail chemicals
were of analyticai grade. Ouabain, Digoxin, Dimethisuifoxide (DMSO), Cocktail
Protease Inhibitors and Hepes were purchased from Sigma Chemical Co. (St. Louis, MO),
NP-40 Alternative was from Calbiochem. Marinobufagenin (MBG) was kindly provided
by Dr. Bagrov (NIH/NIA, Baltimore. MD). Phenylephrine hydrochloride, Carbacol were
obtained from Research Biochemical International. Anti-NaIK-ATPase ai, a3 subunit
antibodies were purchased from Upstage Biotechnology. Mouse monoclonal [AC-15] to
f3-actin-ioading control was from Novus Biologicals. Anti-mouse HRP-linked second
antibody, moiecular weight markers and ECL Western blot detection solution were
purchased from Amersham Biosciences. The BioRad protein assay kit was from BioRad
(Hercuies,CA).
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3.3 Organ Bath Assay
Isolated thoracic aorta was cleaned of fat and connective tissues and cut into consecutive
rings of 3-4 mm. The rings were mounted on stainless steel hooks and placed in
individualjacketed tissue baths (10 ml; Radnotti Glass, Monrovia, CA) maintained at 37
(+ 0.5) °C and oxygenated. In order to exclusively study the regulation of Na pump in
smooth muscle of the vessels, the vascular endothelium was removed by gently rubbing
with injection needle.
The aortic rings were equilibrated for 60 min under 2.0 g passive tension with frequent
washing and tension adjustment. The tissues were bathed in KBS (PH 7.4) of the
following composition: 118 mM NaCY, 4.65 mM KC1, 25 mM NaHCO3, 2.5 mM CaC12,
1.1$ mM MgSO4, 1.18 mM KH7PO4, 5.5 mM dextrose. Normal KBS contained 5.83 mM
of K, with reduced K-KBS had 2.0 mM K’. Tension was measured by isometric force
displacement transducers (FI-03; Grass Instruments, Quincy, MA) and recorded on a
computerized data acquisition system using Work Bench software (Kent Scientific,
Litchfield, CT). Figure 9 illustrates the experiment of organ bath assays.
To confirm the removal of endothelium, after equilibration, the tissues were challenged
with 1.0 1iM phenylephrine (PhE). At plateau responses, Carbacol (10 1iM) was added.
There should be no relaxation present. If any relaxation was observed, the endothelium
was further rubbed. The experiments with ouabain were performed under a sodium lamp
to prevent photo-degradation of this substance.
3.4 Concentration — Response Curves to KCI
b evaluate the contractile effect of ouabain on sodium pump, concentration
— response
curves to KC1 were measured in the presence and absence of ouabain in normal
physiological solution ([Kf] 5.8mM) or in reduced potassium medium ([Kj 2.OmM).
Eight aortic rings from each of non-pregnant, pregnant or experimental preeclamptic rats
were used and divided into two groups; four rings were incubated in normal KBS and the
u
.
1 n
H
- C z z (f2 (f2 r,)
R
el
gt
iv
et
oP
hg
ii
iM
27
other four were bathed in reduced potassium KBS. Afier initial response to PhE and
Carbacol, the solution of halfthe rats were changed to Iow potassium KBS. Afler 60 min
stabilization period, one ring of each group served as control while the other three were
challenged with increasing concentrations of ouabain (0.1, 0.3. 1.0 mM). Fifleen min
later, KC1 (2.0 mM to 100 mM) was cumulatively added to the baths (Complete protocol’
see Fig.10). figure 11 shows a typical experimental record ofKCl-induced concentration.
Isolated thoracic aorta was cut into consecutive rings of 3-4 mm,
which were endothelium denuded and installed in individual tissue
bath fihled with oxygenated Krebs solution (KBS).
8
The rings were equilibrated for 60 minutes under 2.0 g passive tension.
Tension was measured by force-dispiacement transducers and was
recorded on a computerized data acquisition system.
8
Afier equilibration, tissues were challenged with phenylephrine 1.0 1iM
and carbacol 0. lmM to verify removal of endothelium.
8
After 60 minutes’ relaxation, the aortic rings were incubated with ouabain(0.1, 0.3, 1.0 mM). fifteen minutes later, KCI (2.0 to 100 mM) was
cumulatively added to the bath.
Figure 10. Experiment protocol of KCI-induced contraction
2$
3.5 Relaxation Curves to KCI
To further measure the inhibitory activity of Na pump ligands, another indicator of the
functional activity of the NaJK-ATPase, K- induced relaxation in a K- free environment
was conducted in aortic rings of pregnant and non — pregnant rats. Afier equilibration, ail
eight rings were exposed to K- free solution. The K - free buffer solution (PH 7.4) was
prepared by substituting KH2PO4 and KC1 with NaH2PO4 and NaCI, respectively, on an
equimolar basis. Then, one ring used as control, three were treated with different
concentrations ofouabain: 0.01, 0.03, 0.1 mM, two were treated with digoxin I j.tM and
0.1 j.iM and 2 tissues with marinobufagenin (MBG) 0.1 jiM and 0.01 11M. Afier 5 mm,
they were made to contract with PhE 1.0 11M. At plateau response, KC1 was gradually re—
added into the tissue bath in a cumulated fashion (0.1-6.0 mM) to induce a relaxation
curve. The relaxation response afier each addition of KC1 reached a steady state within 3-
5 min. In the present experiment, Phenylephrine (lliM) was used for two times. The first
application was to conform the removal of endothelium, and the second one was to
produce a contraction before the KC1-induced relaxation. (Complete experimental
protocol see fig.12). figure 13 shows a typical record ofKCl-induced relaxation.
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Figure 11. Experiment record ofKCl-induced contraction
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The same steps as in KC1-induced contraction
1
Verifying the rernoval of endothelium
8
Afier 60 minutes’ relaxation, the aortic rings were incubated in
K+ free solution and were treated with inhibitors. Then they were
precontracted with phenylephrine (1 tM).
I
At plateau response, KC1 xvas gradually re-added into the tissue
bath to induce a relaxation curve. The inhibitory activities of
ouabain, digoxin and marinobufagenin on the KCI — induced
relaxation were measured.
Figure 12. Experiment protocol ofKCI-induced relaxation
3.6 Tissue Protein Preparation
Five aortas of non-pregnant, pregnant or experimental PE rats were collected, frozen and
powdered in liquid nitrogen. Tissue were homogenized in ice-cold buffer t Hepes 20 mM,
NP-40 Alternative 1%, PH 7.4) containing 10% cocktail protease inhibitors (Table 2).
Nonidet P-40 is a nonionic mild detergent which can solubilize the target proteins in an
immunoreactive and undegrated form. The homogenates were centrifuged at 3000 rpm
tHermie Z360K) for 10 min at 4°C to get rid of the nuclei and debris. The supematant
fraction was recovered and the protein concentration was rneasured by the Bradfrod
method (BioRad). Then the quantified protein sampies were mixed with electrophoresis
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indicator Laernrnli to make a final protein concentration of 1 .5 mM. The extracts were
kept ice cold during this experiment and were stored in -20°C for further use.
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Figure 13. Experiment record of KC1-induced relaxation
Table 2. Cocktai] Protease Inhibitors
Inhibitors Concentration (mM) Proteases
AE 3Sf 2 Saine
ED+A 1 Metallo
Bestatin 0.13 Amino peptodases
E-64 0.0 14 Cysteines
Leupetine 1 Serin-cysteine
A protein 0.0003 Saine
3.7 Western Blot
Rat kidney microsorne (Upstate Biotechnology) was used as positive control for the al
isofonn ofNaJK-ATPase and brain microsome for the a3. The sample was denatured by
heating to 100°C for 5 min in boiling water. Then 30 — 45 ig protein of thoracic aorta
and conesponding positive control (2Opg microsome), as well as molecular standard
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(10ig. BioRad) were loaded into wells in a BioRad mini-protean II electrophoresis celi
and separated on poÏyacrylarnide gel with Tris-Glycine-SD running buffer (in M: Tris
base-0.25, glycine-1.92 and SDS-l%). Electrophoresis lasted for about 30 min at 150 mV
until the front of samples ran to the edge of the gels. The gels were removed from the
glass plates and transferred to Hybond-ECL nitrocellulose membranes (Amersham
Biosciences) for 2 hours at 75mV at 4°C, using a mini Trans-Blot Transfer Celi System
(BioRad). The transfer buffer contains (in mM): Tris-base-50, glycine-380 and methano
20%. Then the membrane was blocked overnight at 4°C in TBS-Tween solution (in mM:
Tris-base-50, NaCY-150, Tween 20-0.1%, PH 7.5) with 5% powdered non-fat milk. Next,
the membrane was incubated and shacked for 60 min at room temperature with primary
antibody anti-al (Upstate Bioeclmology) mouse monoclonal IgG (1:4000 dilution), anti
a3 (Upstate Bioteclmology) rabbit polyclonal antibody (1:1000 dilution) and J3-actin-
loading control (1:15000) (Table 3). The antibody dilutions were optimized to maximize
signal and minimize background. Afier washing with TBS-Tween buffer for three times
(3x10 min washes), the membranes were incubated for 30 min with second antibody
—
anti-mouse (1:2000 dilution) or anti-rabbit (1:4000 dilution) IgG antibody conjugated to
horseradish peroxidase (Amersham International). The membranes were thorough
washed for two tirnes (each 10 mm) and were visualized with an enhanced
chemiluminescence detection kit (Amersham Biosciences) and exposed to ECL
Hyperfilm (Amersham Bioscience) for 30s to 60s (f3-actin for 6s). The films were then
developed.
Quantification of the relative protein content was determined by scanning the blots and
measuring the spot density using Aiphalmager program. Because of differences in
background intensity, the abundance of the detected protein was nonnalized to that of f3-
actin.
3.8 Data Ana]ysis
Vasoconstrictor responses induced by KC1 were expressed as a ratio of the contraction to
KCI related to that previously obtained with phenylephrine (PhE) 1 iM (data not shown).
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Table 3. Western Blot Antibodies
Exposure Time
Antibody Dilution (s)
al anti-mouse monoclonal 1 :4000 50
Primar’
a3 anti-rabbit polyclonal I : 1000 120
Antibody
anti-mouse f3-actin-loading
control 1:15000 6
anti-mouse 1:2000
Second Antibody
anti-rabbit 1:4000
Each concentration-response curve to KC1 was analyzed by computer fitting to a 4-
pararneter logistic equation with the program prism 4.0 version (Graphpad software, San
Diego, CA) using non-liner regression analysis, to evaluate the concentration producing
50% of the maximal response (EC5O) and the maximum response (Emax). Data are
expressed as mean experimental points with their standard error (SEM), together with the
best-fitted curve to these points. Statistical significance was determined with a 2-tailed
test comparing the means of independent sample groups. In K-induced relaxation curves,
2-way ANOVA was used for comparison of remaining contractions among groups.
b determine the protein expression of a isoforms of the NaIK-ATPase, resuits are
expressed as relative density of protein bands in each isoform to those of Ç3-actin on the
same gel. Preliminary experiments showed that increasing the loaded protein
concentrations gave proportional f3-actin and al signals. Data were analyzed with
Student’s t-test for unpaired experiments. A P value of less than 5% was considered
significant.
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4. Results
4.1 Contractile Effect of Ouabain
figure 14 shows contractile responses induced by ouabain in isoÏated aortic rings of non
pregnant and pregnant rats with or without sait supplement and obtained in normai ([Kj
5.$3mM) or Ktreduced ([Kj 2.0 mM) physiological solution. In normal physiological
medium (Fig.14A), aortic ring contracted to ouabain (0.3 mM) similariy in the different
groups except in non-pregnant rats with NaC1 suppiement. Conversely, with 1.0 mM
ouabain the response was similar in ail the groups, except pregnant rat on sodium
supplement. This suggests that the inhibitory effect of ouabain on the sodium pump is
reduced in the experimental preeclarnptic model.
In the presence of K-reduced solution (Fig.14B), the contractile effect of ouabain on
aortic ring was increased in ail conditions, except in normai pregnant rats at 1.0 mM,
compared to normal physiologicai solution (Fig.14A), but there was no statistical
difference between the 2 concentrations of the inhibitor of the sodium pump. In addition,
ouabain 0.1 mM induced contraction in each group (except in normal pregnant rats),
which was absent in normal physiological medium. These results suggest that the pump
+activity is increased upon bathing aortic rings in low K solution, and that pregnant
animal is resistant to this increase in activity, not the preeclarnptic ones.
4.2 Vasoconstrictory Response to KCI
Tables 4 and 5 report the effects of 0.9% NaCl supplement on maximal responses and
sensitivity to KCI without and with ouabain 0.3 or 1.0 mM pre-contraction in aortic rings
ofnon-pregnant and pregnant rats in normal and low K physiologicai solution. figurel5
and 16 show the concentration-response curves to KC1. In normal physiological solution,
the maximal response to KC1 in the absence of ouabain is reduced in aortic rings of
pregnant compared with non-pregnant rats on normal sait intake (ftom 1.14 ± 0.06 to
A [K+] 5.83 mM
Ouabain 0.3 mM
Ouabain 1.0 mM
j
•t’:
ç’0 ç.0
C> C>
34
1.0-
0.8
o
4-
Q)
>
4-
0.4
o
J:
1.1-
0.9
0.7
0.5
Q)
0.3
o
4-
Q
0.1
o
-0.1
Figure 14. Contraction induced by ouabain on the aortas of non
pregnant and pregnant rats in normal and increased sodium intake.
Rings were incubated in a solution containing 5.83 mM (A) or 2.0 mM
(B) of [K+].
B [K+]2.OmM
Ouabain 0.1 mM
Ouabain 0.3 mM
Ouabain 1.0 mM
&C> C>
ç.0 ç’O
qO) ç.
35
0.98 ± 0.03, P < 0.01, table 4) but no change during 0.9% Naci supplementation.
Sensitivity to KCI is also decreased (from 1.85 ± 0.06 to 1.58 + 0.03, P< 0.01), again with
no change in 0.9% NaCl intake. High salt intake in pregnant rats (experimental
preeclamptic rats) did flot affect maximal response or sensitivity to KCÏ.
Concentration-response curves to KC1 that were obtained afier stimulation by ouabain in
non-pregnant 0.9% sait intake and normal pregnant rats shifted to the lefi, showing that
ouabain potentiated the response to KC1 in these two groups. For example, in the former
group, maximal responses to KC1 in the presence of both o.3 and 1.0 mM ouabain
significantly increased compared with control (from 1.16 ± 0.04 to 1.40 ± 0.04, P <0.05
and to 1.46 ± 0.05, P < 0.05, respectively, table 4), and the sensitivity to KC1 is also
higher in the pre-incubation of 1.0 mM ouabain (from 1.86 ± 0.04 to 2.04 ± 0.06, P <
0.05). In normal pregnant group, maximal response to KC1 is statisticaily enhanced (from
0.98 + 0.03 to 1.10 ± 0.03, P < 0.05), and sensitivity also increased in the presence of
both 0.3 and 1.0 mM oubain (from 1.58 + 0.03 to 1.70 + 0.02, P <0.05 and to 1.91 + 0.04,
P <0.01, respectively). However, ouabain did flot produce potential effect on reactivity to
KC1 in experimental preeclamptic rats.
These data reveai that the aortic reactivity to KC1 was diminished during normal
pregnancy but not in PE. Ouabain increased the vascular reactivity to KC1 in non
pregnant high sodium intake rats and pregnant rats in regular diet. Experimental PE
obliterated this enhanced response to KC1.
In low K solution. similar to normal physiological medium, the maximal response and
sensitivity to KC1 are reduced in pregnant rats compared to non-pregnant rats in normal
diet (from 1.24 ± 0.04 to 1.03 ± 0.02, P< 0.05, and from 1.76 + 0.03 to 1.54 ± 0.03, P<
0.05, respectively, table 5). But in experimental preeclamptic group, there were no
significant changes in maximal response or sensitivity to KC1 compared to normal
pregnant rats. In addition, low potassium medium also enhanced the maximal response to
KC1 in each group.
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Table 4. Parameters of concentration-response curve to KCI in aortic
rings, bathed in normal physiological solution, from non-pregnant and
pregnant rats on normal and increase sodium intake.
Basal responses Emax EC5O
Np Ctl -0.004 + 0.10 (10) 1.14 ± 0.06 0.014 (1.85 ± 0.06)
oua0.3 0.04±0.08 (9) 1.11±0.04 0.014(1.85±0.05)
oua 1.0 0.34 ± 0.09* (9) 1.24 ± 0.05 0.011 (1.94 ± 0.07)
NpO.9% -0.01 ±0.07 (8) 1.16±0.04 0.014(1.86±0.04)
oua0.3 0.14±0.07 (8) 1.40±0.04* 0.011(1.96±0.03)
oua 1.0 0.36 ± 0.09* (8) 1.46 ± 0.05* 0.009 (2.04 ± 0.060*
Pg Ctl -0.02 ± 0.03 (11) 0.98 ± 0.03 0.026 (1.52 ± 0.03)
otia 0.3 0.02 ± 0.04 (11) 0.99 ± 0.03 0.020 (1.70 ± 0.02)*
oua 1.0 0.22 ± 0.04* (11) 1.10 ± 0.03* 0.013 (1.91 ± 0.04)*
Pg 0.9% 0.00 ± 0.08 (6) 1.08 ± 0.07 0.024 (1.63 ± 0.09)
oua 0.3 0.02 ± 0.10 (6) 1.20 ± 0.07 0.019(1.72± 0.05)
oua 1.0 0.16 ± 0.10 (6) 1.16 ± 0.08 0.020 (1.69 ± 0.07)
Values are means ± SE (n=$). Basal response is the tone left afier 15 min preincubation
with ouabain; EC5O, in molar concentration with logEC5O in parenthesis; Emax in
relative response to PhE (luM). * vs respective control and . vs non pregnant control.
Figure 15. Concentration-response curves to KC1 in aortic rings from
non-pregnant and pregnant rats in normal diet and on 0.9% NaCI
supplement. Rings were incubated in normalphysiotogical solution.
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In the presence of ouabain, concentration-response curves to KCT shifted to the lefi, the
same situation as in normal physiological environment, demonstrating the potential
function of ouabain in response to KC1 in low K solution, especially in sensitivity. EC5O
reduced in aIl the groups with 1 .0 mM oubain preincubation. and in normal pregnant rats,
EC5O decreased with both 0.03 and 1.0 mM ouabain preincubations. As shown in table 5,
in control group, sensitivity was increased from 1.76 ± 0.03 to 2.03 ± 0.10, P< 0.01; in
non-pregnant 0.9 ¾ NaC1 group, from 1.81 + 0.05 to 2.02 ± 0.07, P <0.05; in normal
pregnant rats, from 1.54 + 0.03 to 1.67 ± 0.04, P <0.05 (ouabain 0.03 mM) and to 1.76 ±
0.05, P <0.05 (ouabain 1.0 mM); in experimental preeclamptic rats, from 1.54 ± 0.07 to
1.92± 0.11, P <0.01.
These resuits indicate that vascular response to KC1 is decreased during normal
pregnancy but not in PE. Ouabain potentiates this response in aortic rings ofpregnant rats.
4.3 Relaxation Curves to KCI
Relaxation curves induced by KC1 in K-free solution were measured in aortic rings of
virgin and pregnant rats in the presence or absence of the three inhibitors of NaJK
ATPase, shown in figure 17 and 18. Ouabain induced a concentration dependent
inhibition of relaxant effect of KC1 in both pregnant and non-pregnant groups (Fig.17).
Preincubation with ouabain 0.lmM signifucantly inhibited the KC1-induced relaxation
and ouabain 0.03 mM and 0.01 mM partially blocked the response.
Decrease in relaxation to KC1 in the presence of ouabain vs control was significantly
higher in pregnant rats compared with non-pregnant group. For example, at the point of
[KCJ] 3 mM, in pregnant rats, the relative relaxation magnitude of the control was 1.23,
and the decreased relaxation with ouabain 0.01, 0.03 and 0.1 mM preincubation were
0.48, 0.96 and 1.11, respectiveÏy. In non-pregnant group, the relative relaxation
magnitude of the control was 1.46, and the reduced relaxation in the presence of ouabain
0.01, 0.03 and 0.1 mM were 0.17, 0.60 and 1.21, respectively. There was no difference of
reduced relaxation with inhibition of 0.1 mM ouabain, since it almost totally blocked the
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Table 5. Parameters of concentration-response curve to KCI in aortic
rings, bathed in low K solution (2.0 mM), from non-pregnant and
pregnant rats on normal and increase sodium intake.
Basal responses Emax EC5O
NpCtI -0.004±0.07 (10) 1.24±0.04 0.01$ (1.76±0.03)
oua 0.3 0.40 ± 0.10* (9) 1.19 ± 0.07 0.015 (1.82 ± 0.09)
oua 1.0 0.65 ± 0.10* (9) 1.26 ± 0.05 0.09 (2.03 ± 0.10)*
Np 0.9% 0.01 ± 0.10 (8) 1.26 ± 0.06 0.015 (1.81 ± 0.05)
oua0.3 0.39±0.11* (8) 1.21±0.06 0.012(1.92±0.08)
oua 1.0 0.59 ± 0.09* (8) 1.32 ± 0.05 0.0 10 (2.02 ± 0.07*
Pg CtI -0.02 ± 0.03 (12) 1.03 ± 0.02 0.029(1.54 ± 0.03)
oua 0.3 0.15 ± 0.05* (12) 1.12 ± 0.05 0.022 (1.67 ± 0.04)*
*
oua 1.0 0.13 ± 0.07 (12) 1.13 ± 0.05 0.017 (1.76 ± 0.05)
Pg 0.9% -0.02 ± 0.09 (6) 1.10 ± 0.08 0.029 (1.54 ± 0.07)
oua0.3 0.46±0.16* (6) 1.24±0.12 0.021(1.69±0.12)
oua 1.0 0.39±0.14* (6) 1.27± 0.08 0.12 (1.92±0.11)*
Values are means ± SE (nr=8). Basal response is the tone left after 15 min preincubation
with ouabain; EC5O. in molar concentration with logEC5O in parenthesis; Emax in
relative response to PhE (luM). * vs respective control and . vs non pregnant control.
figure 16. Concentration-response curves to KCI in aortic rings from
non-pregnant and pregnant rats in normal diet and on 0.9% NaCI
supplement. Rings were incubated in u redttcedpotussiuin solution.
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KCI-induced relaxation in both groups. But the decreased relaxations in the presence of
ouabain 0.01 and 0.03 mM were much iess in aorta of non-pregnant than pregnant rats.
These data show an increased inhibitory activity of ouabain on aortic rings of pregnant
rats, suggesting Na!K-ATPase enzyme activity may be stimulated during gestation. The
differences in the relaxation responses would not be affected by the magnitude ofthe pre
contractions induced by PliE, as the differences of pre-contractile tone were flot
significant between aortic rings of non-pregnant and pregnant animais.
Digoxin (0.1-1.0 p.M) and MBG (0.01-0.1 jiM) did not produce inhibition to K-induced
relaxation (Fig. 18), which suggests the difference in sensitivity of NaIK-ATPase during
pregnancy does flot seem to be associated with the presence of different isoforms of the
sodium pump.
4.4 Western Blot Analysis of Na/K-ATPase OEl and cL3 isoform expression
f igure 19 shows cd isoform protein expression detected in thoracic aorta ofpregnant and
non-pregnant rats using monoclonal anti-cL 1 antibody, and figure 20 shows that in aorta of
pregnant and experirnental PE rats. This is close to the expected moiecular mass of100
KDa in vascular sodium pump. Expression of al-subunit did not change in pregnant rats
compared with non-pregnant ones, but significantly increased in preeclamptic rats
compared with normai pregnant ones (Table 6). The al is the predominant isoform
detectable by Western Blot. But the a3 isoform was undetected in homogenate in the
vessels studied.
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flot have any inhibitory effect on KCJ-induced relaxation.
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Table 6. OEl isoform Protein expression changes with pregnancy ami
experimental PE
Group Mean relative signal intensity N P value
Pg 0.080 ± 0.015 5 X 3
Vs 0.369
Np 0.098+0.013 5X3
Pg 0.306±0.093 5X3
Vs 0.0089
Pg ± 0.9% NaCÏ 0.63 04 ± 0.067 5 X 3
Relative signal intensity is optical density ratio of cd isoform to J3-actin. Resuits are
derived from 5 different pools of tissues, mach measured in triplicate.
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5. Discussion
5.1 Overview
Pregnancy is associated with profound physiological alteration in vascular behavior.
including a marked vasodilation and refractoriness to vasopressor responses. PE is a
pregnancy-specific syndrome that is characterized by a marked increase in peripheral
vascular resistance and in vascular tone. The mechanisms mediating the latter increased
are incompletely understood. One ceilular transport system affecting smooth muscle tone
is the NaIK-ATPase, which plays a key role in regulating membrane potential. Reduction
in its activity can result in increased muscle contraction [67]. We hypothesize that sodium
pump activity and Œ-isoform expression in vascular smooth muscle would be modified in
response to pregnancy and PE. To study any change in activity of the sodium pump in
these physiological and pathological states, we measured 1) contractile effects ofouabain
on isolated aortic sodium pump in normal physiological and low K solutions, 2) KC1-
induced relaxation in a K-free medium in the absence or presence of sodium pump
ligands, 3) NaIK-ATPase protein expression in aorta of normal pregnant and
experimental preecalmptic rats.
To establish the animal model of PE, 0.9% NaC1 as drinking water was given to pregnant
rats from day 15 to 22 of pregnancy, correspondent to the third week of gestation in this
specie. The major findings were as foliowing: 1) Ouabain produced contractions on
isolated aortic rings. That vas increased in low K solution, as well as in non-pregnant
rats with high sait diet. 2) Pregnancy showed refractoriness to vasoconstrictor effects of
KCY, but experimental PE obiiterated it. 3) Responses to KC1 were increased in the
presence of ouabain in ail groups except experimentai preeciamptic rats. 4) Relaxation to
KC1 was significantly reduced in aorta from pregnant compared to non-pregnant rats.
Ouabain produced concentration-dependent inhibition in this relaxation, that was
significantly larger in aorta of normal pregnant than in non-pregnant rats. 5) Expression
of al subunit of sodium pump did flot change in aortas of pregnant rats, but was
significantly increased in aorta ofpreeclamptic rats.
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5.2 Ouabain-Induced Contraction
Ouabain bas been shown to have pro-hypertensive effect in in vivo studies [130-132].
Chronic administration of ouabain was accompanied by increases in blood pressure [130]
and mild hypertension [131] in normotensive rats. Upon withdrawal of ouabain
administration, blood pressure and plasma ouabain levels normalized within 1 week,
showing a reversible hypertensive effect of ouabain [132]. In the present in vitro study,
our resuit also showed that ouabain induced contractile responses in isolated rat aortic
rings (Fig.14). This contraction after the sodium pump blockade in vascular smooth
muscle can be produced through the inversion of the NaICa exchange, resulting in the
rise in cytosolic Ca2 and intracellular stores of Ca2 [22, 23]. This causes the increased
contractility and reactivity that underiies the increased vascular tone and peripheral
vascular resistance that elevates the blood pressure.
Other cellular mechanisms involved were also reported, such as a direct effect on
vascular smooth muscle mediated by depolarization and opening of the voltage-gated
calcium channels (VDCC) [15, 128]. However, the contribution ofVDCCs to the ouabain
effect has been variable. depending on the contribution of the NaJK-ATPase to the
membrane potential of the respective smooth muscle ceils [22, 85]. For example, the
transient contractile response induced by ouabain in umbilical arteries is sensitive to the
2+Ca channel blockade [129].
As shown in Fig.14a and Table 4 (Basal response), in normal physiological solution,
ouabain 1.0 mM induced contraction in ail the groups, but the response was smafler in
experimentai preeclamptic rats. This reduced inhibitory effect of ouabain on sodium
pump in experirnental preeclampsia suggests that aortic ring sodium pump activity is
altered by high sait loading in pregnant rats. The aitered activity of NaJK-ATPase resuits
in reduced sensitivity to ouabain. Study of the modulation of the response of rat thoracic
aorta to several constrictors [74] proposed that during pregnancy, sodium loading affects
some mechanisms in aortic smooth muscle that are important for receptor-couple
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vasoconstriction but flot for depolarization-induced response. However, the exact
mechanisrn of PE on vascular Na!K-ATPase needs to be further investigated.
In low K-medium (fig. 1 4b and Table 5 Basal response), ouabain-induced contractions
were much larger than that in normal physiological solution, exceptin aorta ofthe normal
pregnant rats. This indicates that reduced extraceHular K increases the inhibitory activity
of ouabain on sodium pump, but pregnancy diminishes this hypertensive influence,
indicating some resistance to the depolarizing effects of ouabain in aortic smooth muscle
has taken place. This suggests the vascular sodium pump is activated during pregnancy.
In addition, the contractile response of ouabain (1.0 mM) was more pronounced in non
pregnant rats on regular diet than in normal pregnant ones when rings were bathed in
either of the two extracellular K concentrations, showing a pregnancy-induced decreased
response to the membrane depolarization function of ouabain.
5.3 Vasoconstrictor Activïty
Vascular reactivity experiments have shown that pregnancy is often associated with
blunted reactivity to many vasopressor agents [65, 66, $0-$4]. This is also true in the
present investigation. Table 4 and 5, and figure 15 and 16 showed that both maximal
response and sensitivity to KC1 were significantly reduced in aortic rings of pregnant
compared to non-pregnant rats in both normal physiological and reduced K solutions. It
was demonstrated that the diminished response of aorta from pregnant rats to BAY K
$644, a dihydropyridine calcium channel activator, was overcome by preincubating aortic
rings of pregnant rats in 10 mM KC1, suggesting that the blunted responses of blood
vessels of pregnant rats could be dependent on altered membrane potential [77].
Electrophysiological data also reported that smooth muscle ceils of mesenteric resistance
arteries of pregnant rats were hyperpolarized by 7 mV [80]. This means that
hyperpolarization of plasma membrane in blood vessels decreases sensitivity to the
membrane potential depolarization effect of KC1, supporting the hypothesis that the
vascular sodium pump is activated during pregnancy, since it plays a main role in resting
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membrane potential regulation. Its activation during pregnancy contributes to this
membrane hyperpolarization.
0f course membrane potential is largely regulated by its K permeabihty. Which mostÏy
depends on K’ channels, more precisely on their open probability and on K gradient
across the plasma membrane. K channels, when open, maintain or help to recover a
basal state of polarization and modulate any depolarizing effects produced by Ca2 or Na
influx or CF efflux. Previously, we studied the effects of K channel modulations on
myotropic responses of aortic rings of pregnant rats and it was shown that two important
K channeis, the ATP-sensitive K channels (KATP channel) and high-conductance
calcium-activated K channels (Bkca chanriel) were invoived in the blunted responses to
vasoconstrictors that accompany normal pregnancy [128].
Although the K gradient aiways bas a major influence on the membrane potential,
changes in the activity of the sodium pump or of other ions gradients (e.g. Na gradient)
can also have significant effects [119], that remain to be thoroughly investigated.
In non-pregnant animai on 0.9% NaCl supplement, only minimal change in reactivity to
KCI was observed compared with non-pregnant rats in normal diet. which supports the
observation [$6] that phenylephrine caused a stress slightly greater in aortic strips of non
pregnant rats in high salt diet cornpared with those in normal diet.
In experimental PE, no significant change in response to KC1 was present compared to
normal pregnancy, indicating tiiat high sait intake obliterates the decreased sensitivity to
vasoconstrictor observed in normal pregnancy. This is consistent with the studies
showing that sodium supplement flot only prevented the end gestational decrease in blood
pressure [42], but also reversed the pregnancy-associated blunting reactivity to
phenylephrine, KC1 and AVP [74].
To study the involvement of the sodium pump in vascular smooth muscle effects of
vasoconstrictor during normal pregnancy and PE, concentration-response curves to KC1
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of aortic rings preincubated with ouabain, a potent inhibitor of the electrogenic sodium
pump, in normal physiological and low K solutions were measured, since we expected
that alteration in activity of the vascular sodium pump may cause different response to
KC1 during normal pregnancy and in PE.
In the normal pregnant group, the lefiward shified concentration-response curve and the
decreased EC5O show that ouabain potentiates the response to KC1 in aorta of pregnant
compared to non-pregnant rats in both normal physiological and reduced K solutions,
indicating that ouabain increases the response of sodium pump induced by KCI, the
voltage depend stimuli, during pregnancy. Ouabain influences the mechanism of
membrane potential regulation of the aortic sodium pump more markedly, suggesting the
activity of the ouabain-sensitive NaIK-ATPase is increased during this special
physiological state. However, experimental PE was flot associated with increased
sensitivity to KCI in the presence of ouabain. It suppressed this potentiation of
vasoconstriction induced by depolarization in pregnant rat rings, indicating that high sait
loading may has already depolarized the plasma membrane by deactivating the Na!K
ATPase in pregnant rats. This deactivation might be achieved in two general ways: a
reduction in the number of sodium pump units or an increase in level of endogenous
circulating sodium pump inhibitors, which is aiso reported in wornen with PE [69]. Our
Western blot result shows an increase in protein expression of the vascular sodium pump
of experimental preeciamptic compared to normal pregnant rats (fig.20). Therefore, the
blunted vascular NaJK-ATPase activity of PE is not due to a reduction in the density of
the pump, but a functionai inhibition due to the circulating sodium pump ligands. The
present observation is in accordance with the fact that endogenous sodium pump ligands
are increased during pregnancy and even more in PE.
5.4 Relaxation to KCI
In this study, the inhibitory activities of ouabain, digoxin and MBG in K-induced
relaxation of contraction produced in a K-free medium were measured to further
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investigate the activity change of sodium pump in vascular smooth muscle during
pregnancy.
According to its working principle, the Na/K-ATPase does not work in the absence of
extracellular potassium ion. Omission of K from the incubation medium resuits in
almost total inhibition of the Na pump [62], which can affect intraceliular Ca2 and
promote smooth muscle contraction in foilowing ways: (1) The inhibition cause
depolarization and increases the influx of Ca2 through voitage-dependent calcium
channeis (VDCC) [621. As mentioned above, membrane potentiai is mainiy generated by
the K equilibrium mechanism, and VDCCs are dependent on this potential for their
activity. The absence of extracellular K will greatly resuit in a shifi in the membrane
potential to a less negative value, and this depolarization causes VDCCs to open. (2)
Passive Na leak through ccli membrane during NafK-ATPase inhibition aiso increases
intracellular Na and decreases the plasmalemmal Na gradient, thus reducing the
extrusion of Ca2 by the NaJCa exchange mechanism and leading to increase intracellular
Ca2 [3].
When K is graduaily returned to the organ bath, NaJK-ATPase wouid progressively be
activated and outward current of positive charge would repolarize the celi membrane of
the vascular rings [64], thereby initiating smooth muscle relaxation. As extracellular K
concentration is increased, the relaxation continues until extracellular potassium ion
concentration reaches equilibrium with intracellular K, further addition of KC1 wiil
depolarize the membrane, stimulating Ca1 influx and produce a reversai contraction.
Therefore, the magnitude of rciaxation that accompanies the introduction of K is a
measure of the activity of sodium pump. However, when sodium pump was blocked by
its inhibitors, relaxation of aortic smooth muscle may be partially or totaliy inhibited.
Thus, the inhibitory activities of ouabain, digoxin and MBG on the KC1-induced
relaxation were detennined.
figure 17 shows significant attenuation in relaxation to KCI in aorta from pregnant
compared to non-pregnant rats. This observation indicates that ouabain-sensitive NaJK
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ATPase may be deactivated during normal pregnancy. However, ouabain produced a
concentration-dependent inhibition in this relaxation to KC1, which was statistically
higlier in aorta of pregnant than in non-pregnant rats, showing that sodium pump is
activated during pregnancy. It is challenging to explain this discrepancy. KC1-induced
relaxation is indicative of NaJK-ATPase activity. Other factors may affect this relaxation
response in advance, as mentioned above, endogenous digitalis-like factors, which are
increased during pregnancy. This substance may inhibit the sodium pump in vascular
smooth muscle celis before its activation upon K restoration.
5.5 Western Blot
As discussed above, the Œ-subunit of NaJK-ATPase contains the catalytic site for ATP
and is the specific receptor for digitalic substances. It is expressed as three major
isoforms that differ in turnover rates and in their tissue distribution. It’s been reported
that sodium pump a-subunit expression was altered in response to pregnancy and PE in
critical vascular tissues [$7]. The present experirnent showed that expression of ai
isoform did flot change in thoracic aorta of pregnant rats compared with non-pregnant
ones (f ig.19), but significantly increased in preeclamptic rats compared with normal
pregnant ones (Table 6, Fig.20). Recent observation reported by fedorova et al also
showed that 1.8% NaCl supplementation in pregnant rats resulted in a substantial
increase in the aortic level of al NaJK-ATPase [133]. This shows that pregnancy has no
impact on enzyme abundance of al isoform. The increased expression in experimental
PE may be some compensatory mechanism to oppose the absence of end pregnancy
decreased in blood pressure in this animal model. The expression of a-subunit is also
subject to regulation by various hormones [$8] and altered during experimentally induce
pathological conditions [63, 89]. for example, rat models of pressure-overload cardiac
hypertrophy caused no significant change in the expression of ai, but that a2 expression
was repressed [10, 90, 91]. It is not known if cardiac glycosides or endogenous ouabain
or experimental PE can cause these changes in rat aorta.
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In the present experiment of cd isoform expression detection, non-pregnant animais with
0.9% sodium suppiement were flot necessarily used as the control of experimental PE.
According to the previous observation [42]. 0.9% Na is a low sait loading and did flot
affect systolic blood pressure in non-pregnant rats compared with non-supplemented
control, showing that non-pregnant rats were abie to maintain homeostasis in response to
0.9% sodium supplement [42]. Although oflen provided, non-pregnant animai on high
sodium intake are flot absolutely required, since the controi condition for PE is normai
pregnancy.
The undetectabie levels of the a3 isoform in our aorta may not be surprising. Vascuiar
smooth muscle of rats frequentiy has much more al than a3 (70]. Low a3 subunit may
reflect decreased a3 production transport or membrane insertion, or increased turnover
[$7].
Our resuits indicate that change in the inhibitory activity of ouabain is associated with the
change in expression of the sodium pump. Previous study in our iab reported that plasma
eiectroiytic sait did not change in pregnant animais with 0.9% sodium supplement [42],
indicating that moderate increase in sodium intake is not iikeiy to resuit in higher
intraceliuiar sodium, nor the circuiating ouabain-iike compounds (Fig.21) and Na!K
ATPase activity. Excessive sodium loading, say 4% Na and a longer duration, may
probably leads to the rise in the sodium activity.
To better understand the subject in generai and our experiment findings, a recapitulative
schema about the relationship among PE, ouabain inhibitory activity and sodium pump is
present bellowed (Fig.22).
5.6 Summary of Experiments
The present study attempts to investigate the inhibitory effect ofthe sodium pump ligands
and protein expression of the a subunit of the NaJK-ATPase in isoiated aorta of normal
pregnant and experimentai preeclamptic rats, and determine the change in activity of
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Figure 21. Immunoassay of marinobufagenine (MBG) and ouabain
like compound (OLC) in urine for 24 hours (St-Louis and Bagrov, 2002
unpublished). NP-Co, non-pregnant normal diet. P-Co, pregnant
normal diet.
NaIK-ATPase during normal pregnancy and PE. According to our experimental resuits,
we can corne to the following conclusions: 1) Inhibitory activity of ouabain in aortic
rings of pregnant rats is increased: 2) Experimental PE reduces the inhibitory effect of
ouabain; 3) Activation of sodium pump during pregnancy favor vascular smooth muscle
hyperporization: 4) Increased protein expression of al isoform may be a biological’
compensational effect.
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Figure 22. Scheme of reiationship among PE, ouabain inhibition and
sodium pump activity & expression. (-), inhibitory effect.
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5.7 Future Study
Although the involvement of the NaIK-ATPase in vascular smooth muscle effects of
vasoconstrictors has long been recognized, its role in vascular tone regulation and
myotropic reactivity in response to prcgnancy and PE has only been intensified in recent
times. It’s also an emerging field in celi biology and many questions need to be answer to
understand the exact linkage between the inhibitory effect of NaJK-ATPase and the
change in the number of sodium pump units, and the mechanism implicated in the
alteration of sodium pump activity induced by high sait intake during pregnancy. Aiso we
need to know the regulation of expression of the vascular sodium pump: how they
assemble and traffic to reach its specific localization at the celi membrane during
pregnancy and in the pathological state of PE.
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